End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 USD | -0.30% |
|
+0.64% | +5.30% |
06-11 | BofA Securities Adjusts Oculis Holding AG to $20 From $21, Maintains Buy Rating | MT |
06-11 | Baird Adjusts Price Target on Oculis Holding to $37 From $35, Maintains Outperform Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
494M | - | |||||
52.73B | - | |||||
39B | ||||||
38.52B | ||||||
30.38B | - | |||||
26.39B |
- Stock Market
- Equities
- OCS Stock
- Charts Oculis Holding AG
- Sector Chart